How many insider trades does FilingIQ track for NSPR?

FilingIQ tracks 272 Form 4 insider transactions for NSPR (InspireMD, Inc.), covering filings from Jan 26, 2015 onwards. 14 of those were filed in the last 90 days.

Are NSPR insiders net buyers or net sellers?

Across the full Form 4 history for NSPR, 60 transactions (22%) were open-market purchases and 26 (10%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does NSPR insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is NSPR in?

InspireMD, Inc. (NSPR) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $53.93M.

NSPR insider trading

NasdaqCM Healthcare

InspireMD, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

272

Last 90 days

Buys / sells

22% / 10%

Market cap

$53.93M

About InspireMD, Inc.

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.

Company website: www.inspiremd.com

NSPR insider activity at a glance

FilingIQ has scored 272 insider transactions for NSPR since Jan 26, 2015. The most recent filing in our index is dated May 27, 2026.

Across the full history, 60 open-market purchases and 26 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on NSPR insider trades is 51.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live NSPR trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,165

UNITED THERAPEUTICS Corp

APLS 275

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

GH 191

Guardant Health, Inc.

KYMR 178

Kymera Therapeutics, Inc.

First Tracks Biotherapeutics, Inc.

Frequently asked

How many insider trades does FilingIQ track for NSPR?: FilingIQ tracks 272 Form 4 insider transactions for NSPR (InspireMD, Inc.), covering filings from Jan 26, 2015 onwards. 14 of those were filed in the last 90 days.
Are NSPR insiders net buyers or net sellers?: Across the full Form 4 history for NSPR, 60 transactions (22%) were open-market purchases and 26 (10%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does NSPR insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is NSPR in?: InspireMD, Inc. (NSPR) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $53.93M.

Methodology & sources

Every NSPR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.